help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-0785
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/3/1655    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barber, K. J.
Right arrow Articles by Kilby, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barber, K. J.
Right arrow Articles by Kilby, M. D.
Related Collections
Right arrow Thyroid
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 3 1655-1661
Copyright © 2005 by The Endocrine Society

The in Vitro Effects of Triiodothyronine on Epidermal Growth Factor-Induced Trophoblast Function

K. J. Barber, J. A. Franklyn, C. J. McCabe, F. L. Khanim, J. N. Bulmer, G. S. J. Whitley and M. D. Kilby

Divisions of Reproductive and Child Health (K.J.B., M.D.K.) and Medical Sciences (C.J.M., F.L.K., J.A.F.), The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom; Department of Biochemistry and Immunology (G.S.J.W.), St. George’s Hospital Medical School, London SW17 0RE, United Kingdom; and School of Clinical and Laboratory Science (J.N.B.), University of Newcastle, Newcastle upon Tyne NE1 4LP, United Kingdom

Address all correspondence and requests for reprints to: Professor Mark Kilby, Department of Maternal and Fetal Medicine, Division of Reproductive and Child Health, 3rd Floor, Birmingham Women’s Hospital, Edgbaston, Birmingham B15 2TG, United Kingdom. E-mail: m.d.kilby{at}bham.ac.uk.

The development of the human placenta involves a complex process of tightly regulated proliferation and invasion by extravillous trophoblast into the uterine decidua. Inadequate placentation is a feature of intrauterine growth restriction and other gestational pathology. There is some evidence that T3 plays a role in the regulation of these processes and that T3 may act synergistically with epidermal growth factor (EGF). The aim of this study was to define the expression of thyroid hormone receptors in extravillous trophoblast, elucidate the effects of T3 on both proliferation and differentiation of human trophoblast cells of varying origins, and define the potential interaction between EGF and T3 on these processes. Using immunohistochemistry, specific thyroid hormone receptor isoforms were localized in extravillous trophoblast in first- and second-trimester placental bed biopsies, indicating potential sensitivity to T3. In studies of human trophoblast-derived cell lines and primary cultures of cytotrophoblast cells in vitro, T3 and EGF exerted an antiproliferative effect on an extravillous-like cell line (SGHPL-4) but stimulated proliferation in JEG-3 choriocarcinoma cells. EGF enhanced survival of nonproliferative term primary cytotrophoblast cells and significantly enhanced invasion of fibrin gels by SGHPL-4 cells, an effect attenuated by T3. Both T3 and EGF also significantly enhanced SGHPL-4 motility. These results suggest that EGF and T3 may act synergistically to regulate both proliferation and differentiated function of human trophoblast.




This article has been cited by other articles:


Home page
Hum ReprodHome page
H. L. LaMarca, P. R. Dash, K. Vishnuthevan, E. Harvey, D. E. Sullivan, C. A. Morris, and G. St. J. Whitley
Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases
Hum. Reprod., August 1, 2008; 23(8): 1733 - 1741.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.-R. Du, W.-H. Zhou, F.-T. Yan, X.-Y. Zhu, Y.-Y. He, J.-Y. Yang, and D.-J. Li
Cyclosporine A induces titin expression via MAPK/ERK signalling and improves proliferative and invasive potential of human trophoblast cells
Hum. Reprod., September 1, 2007; 22(9): 2528 - 2537.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S-Y Chan, J A Franklyn, H N Pemberton, J N Bulmer, T J Visser, C J McCabe, and M D Kilby
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.
J. Endocrinol., June 1, 2006; 189(3): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Khare, A. H. Taylor, J. C. Konje, and S. C. Bell
{Delta}9-Tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription
Mol. Hum. Reprod., May 1, 2006; 12(5): 321 - 333.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. E. M. zu Schwabedissen, M. Grube, A. Dreisbach, G. Jedlitschky, K. Meissner, K. Linnemann, C. Fusch, C. A. Ritter, U. Volker, and H. K. Kroemer
EPIDERMAL GROWTH FACTOR-MEDIATED ACTIVATION OF THE MAP KINASE CASCADE RESULTS IN ALTERED EXPRESSION AND FUNCTION OF ABCG2 (BCRP)
Drug Metab. Dispos., April 1, 2006; 34(4): 524 - 533.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society